Inhibition of the TNF Family Cytokine RANKL Prevents Autoimmune Inflammation in the Central Nervous System.

The central nervous system (CNS) is an immunologically privileged site protected from uncontrolled access of T cells by the blood-brain barrier (BBB), which is breached upon autoimmune inflammation. Here we have shown that receptor activator of nuclear factor-κB (NF-κB) ligand (RANKL) on T cells regulates C-C type chemokine ligand 20 (CCL20) production by astrocytes and T cell localization in the CNS. Importantly, mice specifically lacking RANKL in T cells were resistant to experimental autoimmune encephalomyelitis (EAE) due to altered T cell trafficking. Pharmacological inhibition of RANKL prevented the development of EAE without affecting the peripheral immune response, indicating that RANKL is a potential therapeutic target for treating autoimmune diseases in the CNS.

[1]  G. Morgan,et al.  Colonic dendritic cells, intestinal inflammation, and T cell-mediated bone destruction are modulated by recombinant osteoprotegerin. , 2003, Immunity.

[2]  B. Engelhardt,et al.  The anatomical and cellular basis of immune surveillance in the central nervous system , 2012, Nature Reviews Immunology.

[3]  S. Sakoda,et al.  Critical Roles of CXC Chemokine Ligand 16/Scavenger Receptor that Binds Phosphatidylserine and Oxidized Lipoprotein in the Pathogenesis of Both Acute and Adoptive Transfer Experimental Autoimmune Encephalomyelitis1 , 2004, The Journal of Immunology.

[4]  M. Takeuchi,et al.  Orally available pyridinylpyrimidine derivatives as novel RANKL-induced osteoclastogenesis inhibitors. , 2012, Bioorganic & medicinal chemistry letters.

[5]  R. Ransohoff,et al.  Astrocyte-restricted ablation of interleukin-17-induced Act1-mediated signaling ameliorates autoimmune encephalomyelitis. , 2010, Immunity.

[6]  Kosaku Kurata,et al.  Evidence for osteocyte regulation of bone homeostasis through RANKL expression , 2011, Nature Medicine.

[7]  Mark Coles,et al.  Transgenic mice with hematopoietic and lymphoid specific expression of Cre , 2003, European journal of immunology.

[8]  H. Takayanagi,et al.  The tumor necrosis factor family receptors RANK and CD40 cooperatively establish the thymic medullary microenvironment and self-tolerance. , 2008, Immunity.

[9]  M. Shinohara,et al.  NLRP3 inflammasome induces chemotactic immune cell migration to the CNS in experimental autoimmune encephalomyelitis , 2012, Proceedings of the National Academy of Sciences.

[10]  B. Serafini,et al.  Astrocytes are the major intracerebral source of macrophage inflammatory protein‐3α/CCL20 in relapsing experimental autoimmune encephalomyelitis and in vitro , 2003, Glia.

[11]  B. Hemmer,et al.  Th17 lymphocytes traffic to the central nervous system independently of α4 integrin expression during EAE , 2011, The Journal of experimental medicine.

[12]  Y. Kadono,et al.  Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction , 2006 .

[13]  J. Bilsborough,et al.  Regulation of Mucosal Dendritic Cell Function by Receptor Activator of NF-κB (RANK)/RANK Ligand Interactions: Impact on Tolerance Induction , 2002, The Journal of Immunology.

[14]  R. Flavell,et al.  Pancreatic lymph node-derived CD4(+)CD25(+) Treg cells: highly potent regulators of diabetes that require TRANCE-RANK signals. , 2002, Immunity.

[15]  H. Takayanagi,et al.  The cytokine RANKL produced by positively selected thymocytes fosters medullary thymic epithelial cells that express autoimmune regulator. , 2008, Immunity.

[16]  H. Wekerle,et al.  Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions , 2009, Nature.

[17]  I. Nakano,et al.  Tumoral RANKL activates astrocytes that promote glioma cell invasion through cytokine signaling. , 2014, Cancer letters.

[18]  B. Engelhardt,et al.  Interaction of α4-integrin with VCAM-1 is involved in adhesion of encephalitogenic T cell blasts to brain endothelium but not in their transendothelial migration in vitro , 2000, Journal of Neuroimmunology.

[19]  R. Dubose,et al.  A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function , 1997, Nature.

[20]  D. Cua,et al.  Th17 cell development: from the cradle to the grave , 2013, Immunological reviews.

[21]  R. Steinman,et al.  TRANCE (Tumor Necrosis Factor [TNF]-related Activation-induced Cytokine), a New TNF Family Member Predominantly Expressed in T cells, Is a Dendritic Cell–specific Survival Factor , 1997, The Journal of experimental medicine.

[22]  R. Steinman,et al.  TRANCE, a Tumor Necrosis Factor Family Member Critical for CD40 Ligand–independent T Helper Cell Activation , 1999, The Journal of experimental medicine.

[23]  L. Ment,et al.  Early Postnatal Astroglial Cells Produce Multilineage Precursors and Neural Stem Cells In Vivo , 2006, The Journal of Neuroscience.

[24]  B. Engelhardt,et al.  Alpha4-integrin-VCAM-1 binding mediates G protein-independent capture of encephalitogenic T cell blasts to CNS white matter microvessels. , 2001, The Journal of clinical investigation.

[25]  R. Ransohoff,et al.  Natalizumab for multiple sclerosis. , 2007, The New England journal of medicine.

[26]  S. Morony,et al.  OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis , 1999, Nature.

[27]  A. Haeseler,et al.  Central control of fever and female body temperature by RANKL/RANK , 2009, Nature.

[28]  Timothy S. Blackwell,et al.  Regional Neural Activation Defines a Gateway for Autoreactive T Cells to Cross the Blood-Brain Barrier , 2012, Cell.

[29]  B. Engelhardt,et al.  β1 integrins differentially control extravasation of inflammatory cell subsets into the CNS during autoimmunity , 2009, Proceedings of the National Academy of Sciences.

[30]  B. Engelhardt,et al.  C-C chemokine receptor 6–regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE , 2009, Nature Immunology.

[31]  E. Benveniste,et al.  Regulation of CCL20 expression in astrocytes by IL‐6 and IL‐17 , 2012, Glia.

[32]  B. Engelhardt,et al.  Capture, crawl, cross: the T cell code to breach the blood-brain barriers. , 2012, Trends in immunology.

[33]  J. Dungan.  Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis , 2010 .

[34]  D. Hafler,et al.  Fingolimod for multiple sclerosis. , 2012, The New England journal of medicine.

[35]  J. Penninger,et al.  Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells , 2006, Nature Medicine.

[36]  R. Steinman,et al.  Trance, a Tumor Necrosis Factor Family Member, Enhances the Longevity and Adjuvant Properties of Dendritic Cells in Vivo , 2000, The Journal of experimental medicine.